During this webinar; critical information regarding genetic components of dilated cardiomyopathy, and Pfizer’s exciting Phase 3 Clinical Trial for which they are recruiting patients with the LMNA variant.
Topics of the webinar include:
– Genetics and progressive stages of DCM
– Diagnosis, Evaluation of Family Disease Risk, and Treatment
– Explanation of Pfizer’s Phase 3 Clinical Trial for LMNA patients
– Q&A
